Global Knowledge Centre for Antimicrobial Resistance Research and Development

- For Evidence-Based Decision Making and Enhancing Collaboration and Coordination

Dynamic Dashboard

The Global AMR R&D Hub’s Dynamic Dashboard continuously collects and presents information on more than 10 bn USD AMR R&D investments from across the One Health continuum – human, animal, plant and environment. It also presents information on antibacterial products in the clinical development pipeline and incentives for antibiotic R&D.

Incentivising the development of new antibacterial treatments: G7 progress report by the Global AMR R&D Hub and WHO 2023

Following a call to action from the G7, the Global AMR R&D Hub and WHO submitted a joint progress report on actions to incentivise the development of new antibacterial treatments to the G7 Health and Finance ministers. Access the report and read more here.